Literature DB >> 3943787

Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis.

M L Bassett, J W Halliday, L W Powell.   

Abstract

The role of the measurement of hepatic iron in the diagnosis of genetic hemochromatosis was studied, with particular reference to the differentiation of early hemochromatosis from alcoholic siderosis and the critical hepatic iron concentration associated with fibrosis in hemochromatosis. Hepatic iron was measured in 30 homozygous relatives of 17 hemochromatosis probands, 8 heterozygous relatives, 51 patients with alcoholic liver disease and 40 control subjects. Hepatic iron concentrations were greatly increased in the majority of homozygous hemochromatosis subjects, and there was little overlap with the other groups. In the absence of alcoholism, fibrosis or cirrhosis in hemochromatosis was present only with hepatic iron concentrations above a threshold of approximately 400 mumoles per gm (22.3 mg per gm) dry weight. In some heterozygous hemochromatosis subjects and in some alcoholic patients, hepatic iron concentrations were in the range seen in young homozygous subjects. However, an age-related rise in hepatic iron was seen only in hemochromatosis homozygotes, and calculation of an hepatic iron index (hepatic iron/age) resulted in a clear distinction between homozygotes and the other three groups. It is concluded: that chemical measurement of hepatic iron concentration, when corrected for the age of the subject, reliably distinguishes early hemochromatosis from alcoholic siderosis, and, that there appears to be a threshold level of hepatic iron above which there is a high risk of fibrosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3943787     DOI: 10.1002/hep.1840060106

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  82 in total

Review 1.  Magnetic resonance imaging quantification of liver iron.

Authors:  Claude B Sirlin; Scott B Reeder
Journal:  Magn Reson Imaging Clin N Am       Date:  2010-08       Impact factor: 2.266

2.  Preclinical hypogonadism in genetic hemochromatosis in the early stage of the disease: evidence of hypothalamic dysfunction.

Authors:  A Piperno; M R Rivolta; R D'Alba; S Fargion; F Rovelli; A Ghezzi; M Micheli; G Fiorelli
Journal:  J Endocrinol Invest       Date:  1992-06       Impact factor: 4.256

3.  Different forms of iron accumulation in the liver on MRI.

Authors:  İlkay S İdilman; Deniz Akata; Mustafa Nasuh Özmen; Muşturay Karçaaltıncaba
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

Review 4.  Quantification of liver iron with MRI: state of the art and remaining challenges.

Authors:  Diego Hernando; Yakir S Levin; Claude B Sirlin; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2014-03-03       Impact factor: 4.813

5.  Liver cirrhosis as a consequence of iron overload caused by hereditary nonspherocytic hemolytic anemia.

Authors:  Philip Hilgard; Guido Gerken
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

6.  Prognosis and life expectancy in chronic liver disease.

Authors:  A Propst; T Propst; G Zangerl; D Ofner; G Judmaier; W Vogel
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

7.  Characterization of a recombinant that locates the hereditary hemochromatosis gene telomeric to HLA-F.

Authors:  L M Calandro; D M Baer; G F Sensabaugh
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

8.  Clinical penetrance of C282Y homozygous HFE haemochromatosis.

Authors:  Enrico Rossi; Gary P Jeffrey
Journal:  Clin Biochem Rev       Date:  2004-08

9.  Experimental liver cirrhosis induced by alcohol and iron.

Authors:  H Tsukamoto; W Horne; S Kamimura; O Niemelä; S Parkkila; S Ylä-Herttuala; G M Brittenham
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

10.  Effects of experimental hemosiderosis on pancreatic tissue iron content and structure.

Authors:  D Pelot; X J Zhou; P Carpenter; N D Vaziri
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.